Medicus Pharma Ltd (TSE:MDCX) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Medicus Pharma Ltd. has successfully completed the initial phase of its private placement, issuing US$5.17 million in 10% unsecured convertible notes, with potential for an additional amount up to US$10 million. These notes, maturing in 2025, offer semi-annual interest payments and can convert into common shares under specific conditions, such as an initial public offering in the United States or a change of company control. Investors also have the option to convert the notes at a set price or have them repurchased by the company under certain circumstances.
For further insights into TSE:MDCX stock, check out TipRanks’ Stock Analysis page.